ScholarIQanswers from OpenAlex & ORCID
Mary‐Ellen Taplin
ResearcherPublications, citations & collaboration network
Mary‐Ellen Taplin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mary‐Ellen Taplin have?
ScholarIQindexed works
Mary‐Ellen Taplin has 703 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mary‐Ellen Taplin have?
ScholarIQcitation count
Mary‐Ellen Taplin has 25,057 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mary‐Ellen Taplin?
ScholarIQh-index
Mary‐Ellen Taplin has an h-index of 53 in OpenAlex.
What is the i10-index of Mary‐Ellen Taplin?
ScholarIQi10-index
Mary‐Ellen Taplin has an i10-index of 148 in OpenAlex.
What is the ORCID of Mary‐Ellen Taplin?
ScholarIQorcid
The ORCID for Mary‐Ellen Taplin is on the source record.
What is the OpenAlex record for Mary‐Ellen Taplin?
ScholarIQopenalex
The OpenAlex for Mary‐Ellen Taplin is on the source record.
What are the most-cited papers on Mary‐Ellen Taplin?
ScholarIQmost cited works
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury, Ian D. Davis, Johann S. de Bono, Christopher P. Evans, Karim Fizazi, Anthony M. Joshua, Choung‐Soo Kim, Go Kimura, Paul N. Mainwaring, Harry H. Mansbach, Kurt Miller, Sarah B. Noonberg, Frank Perabo, De Phung, Fred Saad, Howard I. Scher, Mary‐Ellen Taplin, Peter Venner, Bertrand Tombal
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Colin C. Pritchard, Joaquı́n Mateo, Michael F. Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind A. Eeles, Olivier Elemento, Mark A. Rubin, Dan R. Robinson, Robert J. Lonigro, Maha Hussain, Arul M. Chinnaiyan, Jake Vinson, Julie Filipenko, Levi A. Garraway, Mary‐Ellen Taplin, Saud H. AlDubayan, G. Celine Han, Mallory Beightol, Colm Morrissey, Belinda Nghiem, Heather H. Cheng, Bruce Montgomery, Tom Walsh, Silvia Casadei, Michael F. Berger, Liying Zhang, Ahmet Zehir, Joseph Vijai, Howard I. Scher, Charles L. Sawyers, Nikolaus Schultz, Philip W. Kantoff, David B. Solit, Mark E. Robson, Eliezer M. Van Allen, Kenneth Offit, Johann S. de Bono, Peter S. Nelson
Transcriptional mediators of treatment resistance in lethal prostate cancer
Meng Xiao He, Michael S. Cuoco, Jett Crowdis, Alice Bosma-Moody, Zhenwei Zhang, Kevin Bi, Abhay Kanodia, Mei-Ju Su, Sheng‐Yu Ku, Maria Mica Garcia, Amalia Sweet, Christopher Rodman, Laura DelloStritto, Rebecca Silver, John A. Steinharter, Parin Shah, Benjamin Izar, Nathan C. Walk, Kelly P. Burke, Ziad Bakouny, Alok K. Tewari, David Liu, Sabrina Y. Camp, Natalie I. Vokes, Keyan Salari, Jihye Park, Sébastien Vigneau, Lawrence Fong, Joshua W. Russo, Xin Yuan, Steven P. Balk, Himisha Beltran, Orit Rozenblatt–Rosen, Aviv Regev, Asaf Rotem, Mary‐Ellen Taplin, Eliezer M. Van Allen